Hospital
Sparrow Clinton Hospital
Sparrow Clinton Hospital was paid $8.68M by Medicaid between Jan 2018 and Dec 2024, across 132 billing codes. Its largest line is 99285, emergency room visit (most serious) — 29% of everything it billed.
33Billing provider infoSPARROW CLINTON HOSPITAL
SAINT JOHNS, MI 48879
SAINT JOHNS, MI 48879
33aNPI1093809824assigned 10/03/2006
33bProvider typeCritical Access Hospital
28Total paid$8.68M
24GClaims185,334
24DCodes billed132
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Michigan
Rank by total paid#8 of 31
Median peer was paid$6.03M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RUSSIAN, MISTY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,688 | $722K | |
| 2019 | 20,981 | $689K | |
| 2020 | 19,484 | $917K | |
| 2021 | 29,054 | $1.39M | |
| 2022 | 33,323 | $1.68M | |
| 2023 | 37,867 | $1.82M | |
| 2024incomplete | 27,937 | $1.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 29% | 6,903 | 6,325 | $2.51M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 6,515 | 6,144 | $1.50M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 7,917 | 7,575 | $1.19M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7.4% | 7,487 | 6,447 | $644K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.5% | 4,613 | 4,152 | $562K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.7% | 2,297 | 2,211 | $412K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.5% | 1,894 | 1,612 | $218K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.8% | 3,935 | 3,354 | $159K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 1,807 | 1,751 | $150K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.7% | 6,431 | 1,961 | $146K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.7% | 4,010 | 3,542 | $145K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.6% | 1,177 | 1,146 | $143K |
120 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.5% | 1,208 | $134K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 2,360 | $107K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,982 | $79K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,305 | $69K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,557 | $62K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 383 | $52K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 525 | $50K |
| 80061 | Lipid panel | <1% | 2,452 | $32K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,274 | $29K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 749 | $20K |
| 76830 | Ultrasound, transvaginal | <1% | 272 | $19K |
| 80053 | Comprehensive metabolic panel | <1% | 11,658 | $16K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,118 | $15K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 407 | $14K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,058 | $12K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 476 | $12K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 80 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,373 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,971 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,093 | $9K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 582 | $8K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 68 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,404 | $6K |
| Q3014 | Telehealth originating site facility fee | <1% | 302 | $6K |
| 97162 | <1% | 129 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 98 | $6K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 81 | $5K |
| 94060 | <1% | 30 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 686 | $5K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 75 | $5K |
| 93976 | <1% | 66 | $4K | |
| 82607 | <1% | 939 | $4K | |
| 86900 | <1% | 493 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,184 | $4K |
| 93971 | <1% | 43 | $3K | |
| 90686 | <1% | 300 | $3K | |
| 86850 | <1% | 895 | $3K | |
| 84439 | <1% | 1,182 | $3K | |
| 86803 | <1% | 531 | $3K | |
| 85027 | <1% | 2,000 | $2K | |
| 82728 | <1% | 529 | $2K | |
| 86780 | <1% | 413 | $2K | |
| 84702 | <1% | 662 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,740 | $2K |
| 0124A | <1% | 73 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,804 | $2K |
| 83550 | <1% | 646 | $2K | |
| G0378 | Hospital observation service, per hour | <1% | 42 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 144 | $2K |
| 82652 | <1% | 109 | $2K | |
| 87631 | <1% | 395 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 668 | $1K |
| 90677 | <1% | 15 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 113 | $1K |
| 83735 | <1% | 2,917 | $1K | |
| 83540 | <1% | 658 | $1K | |
| 73630 | <1% | 161 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,213 | $1K |
| 86140 | <1% | 4,713 | $1K | |
| 82043 | <1% | 478 | $983.87 | |
| 97161 | <1% | 13 | $910.29 | |
| 87340 | <1% | 316 | $893.76 | |
| 82570 | <1% | 471 | $880.95 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 109 | $869.87 |
| 83880 | <1% | 746 | $834.74 | |
| 84703 | <1% | 4,266 | $684.82 | |
| 81001 | <1% | 4,688 | $643.59 | |
| 72110 | <1% | 36 | $588.01 | |
| 85610 | <1% | 2,768 | $510.47 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 35 | $476.00 |
| 85652 | <1% | 1,508 | $461.14 | |
| 80076 | <1% | 1,571 | $432.51 | |
| 90656 | <1% | 28 | $417.75 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 25 | $407.17 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 758 | $404.30 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,482 | $394.80 |
| 83690 | <1% | 3,179 | $376.74 | |
| 86901 | <1% | 481 | $250.93 | |
| 85730 | <1% | 2,466 | $248.40 | |
| 81003 | <1% | 2,032 | $243.55 | |
| 73130 | <1% | 24 | $196.19 | |
| 83605 | <1% | 3,986 | $188.75 | |
| 84484 | <1% | 2,610 | $188.73 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,431 | $187.83 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 188 | $186.88 |
| 82746 | <1% | 41 | $178.66 | |
| 73564 | <1% | 14 | $161.18 | |
| 87077 | <1% | 247 | $88.77 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 706 | $74.21 |
| 85379 | <1% | 482 | $68.69 | |
| 73610 | <1% | 12 | $65.51 | |
| 87420 | <1% | 292 | $35.34 | |
| 81002 | <1% | 38 | $34.45 | |
| 87040 | <1% | 171 | $32.09 | |
| 87186 | <1% | 99 | $31.55 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,496 | $29.07 |
| 87486 | <1% | 13 | $25.89 | |
| 87581 | <1% | 13 | $25.89 | |
| 85007 | <1% | 65 | $16.62 | |
| 91312 | <1% | 69 | $1.00 | |
| 90670 | 0% | 14 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 261 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 162 | $0.00 |
| 90461 | 0% | 96 | $0.00 | |
| 82948 | 0% | 27 | $0.00 | |
| 90715 | 0% | 42 | $0.00 | |
| 90734 | 0% | 12 | $0.00 | |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | 0% | 12 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 26 | $0.00 |
| 94729 | 0% | 24 | $0.00 | |
| 87210 | 0% | 12 | $0.00 | |
| 94726 | 0% | 27 | $0.00 | |
| 90648 | 0% | 14 | $0.00 | |
| 96376 | 0% | 328 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 66 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 307 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 15 | $0.00 |
| 96127 | 0% | 13 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 14 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUSSIAN, MISTY (SUPERVISOR. PROVIDER ENROLLMENT)
Parent organizationSPARROW HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| Edward W Sparrow Hospital Association | Lansing, MI | $125.88M |
| Metropolitan Hospital | Wyoming, MI | $100.96M |
| Sparrow Ionia Hospital | Ionia, MI | $13.76M |
| Sparrow Eaton Hospital | Charlotte, MI | $13.22M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $5.81M |
| Sparrow Carson Hospital | Carson City, MI | $5.48M |
| Edward W. Sparrow Hospital Association | East Lansing, MI | $5.43M |
| Sparrow Ionia Hospital | Ionia, MI | $3.49M |
| Sparrow Eaton Hospital | Charlotte, MI | $3.12M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $2.77M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $2.61M |
| Edward W Sparrow Hospital Association | Lansing, MI | $2.48M |
| Edward W. Sparrow Hospital Association | Mason, MI | $2.44M |
| Sparrow Community Care | Lansing, MI | $2.31M |
| Edward W Sparrow Hospital Association | Lansing, MI | $2.31M |
| Edward W Sparrow Hospital Association | Lansing, MI | $1.85M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $1.83M |
| Edward W. Sparrow Hospital Association | Lansing, MI | $1.65M |
| Sparrow Ionia Hospital | Portland, MI | $1.61M |
| Sparrow Carson Hospital | Ithaca, MI | $1.54M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.